Solarex

Quick links to important sections

Solarex

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Solarex

Quick Facts: Solarex Identity

Property Description
Active Ingredients Homosalate, Octinoxate, Octisalate, Oxybenzone, Padimate O
Form Topical preparations (Lotion, Cream, Oil)
Pharmacological Class Sunscreen Agents
Common Use Protection against solar UV radiation
Origin Synthetic (Organic UV filters)

What is Solarex?

Solarex: Identity and Pharmacological Class

Solarex is an Over-the-Counter (OTC) combination drug product officially classified as a Sunscreen Agent within the Dermatologicals category. Its core function is to provide photoprotection from the damaging effects of ultraviolet (UV) radiation. The regulation of sunscreens as OTC drugs establishes the medical standard of efficacy for these topical preparations. This product is distinctive due to its formulation with five synthetic chemical compounds, a strategy often clinically recognized for achieving robust, broad-spectrum protection.

Composition and Form: Comprehensive Organic UV Filter Blend

The product’s performance is founded upon a blend of five synthetic organic UV filters that serve as the active ingredients: Homosalate, Octinoxate (Ethylhexyl Methoxycinnamate), Octisalate (Ethylhexyl Salicylate), Oxybenzone (Benzophenone-3), and Padimate O. These compounds are classified as chemical filters, functioning by absorbing and transforming UV energy. Combining these multiple agents—a distinguishing feature of this composition—is key to achieving simultaneous absorption across both UV-B and UV-A wavelengths. Solarex is designed for topical administration and is typically marketed in various Topical preparations, such as a non-greasy lotion or cream, with the oil-soluble filters incorporated into an appropriate base.

What General Benefit Does Solarex Provide?

The general therapeutic purpose of using Solarex is to mitigate the risk of acute sun-induced injury, specifically preventing the development of sunburn on the skin. The five-part combination is engineered for comprehensive coverage, with agents like Octinoxate and Padimate O dedicated to the high-energy UV-B spectrum, and Oxybenzone ensuring filtration within the UV-A spectrum. This systematic, broad-spectrum absorption mechanism provides crucial defense, aimed at maintaining the structural integrity of the skin’s surface during periods of sustained solar exposure.

Regulatory References

  1. Sunscreens and Photoprotection - StatPearls - NCBI Bookshelf

What side effects are possible with Solarex?

Possible Side Effects and Safety Information

The official safety profile for Solarex, an over-the-counter combination of five organic UV filters (Homosalate, Octinoxate, Octisalate, Oxybenzone, and Padimate O), is structured around localized adverse events and specific regulatory constraints.


Documented Adverse Reactions

The most commonly documented adverse reactions, according to regulatory classification, are generally localized and affect the Skin and subcutaneous tissue disorders organ class. These reactions are typically not classified with a specific frequency (e.g., common or rare) in standard OTC labeling, but are known to occur. Key categories of officially listed reactions include skin irritation, rash, and allergic contact dermatitis.

Classification Aspect Regulatory Description
Primary Organ Class Skin and subcutaneous tissue disorders
Local Adverse Events Skin irritation, Allergic contact dermatitis, Rash
Serious Adverse Reactions Severe allergic or hypersensitivity reactions

Population-Specific Constraints and Safety Limitations

Official regulatory documents include definitive constraints on the product's use for specific groups. The product is contraindicated for use in individuals with a known hypersensitivity or allergy to any of the five active ingredients. A critical, mandatory safety note specifies that the product requires consultation with a doctor before use in infants under 6 months of age.

Regulatory Context and Absorption

Official government safety reviews of these organic UV filters have documented their systemic absorption into the bloodstream following topical use. This finding has prompted regulatory bodies, such as the FDA, to classify all five active ingredients as requiring further safety data to confirm their definitive status as Generally Recognized as Safe and Effective. This ongoing regulatory context shapes the high-level understanding of the medicine's safety profile beyond local skin effects.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Solarex focuses on the risks associated with accidental oral ingestion of a large quantity, as systemic toxicity from normal topical use is considered highly unlikely. The active ingredient Octisalate breaks down into salicylate, which presents the potential for acute salicylate toxicity when absorbed systemically.

Domain Documented Regulatory Statement
Manifestations Clinical signs may include gastrointestinal irritation (nausea, vomiting), tinnitus, dizziness, and irritability.
Severe Outcomes Severe overdose carries the risk of metabolic acidosis, hyperthermia, and, in rare instances, respiratory failure.
Emergency Action Upon suspected oral overdose, regulatory guidance mandates that users seek immediate medical attention and contact a poison control center immediately.

Management and Monitoring

Management is restricted to symptomatic and supportive treatment; no specific antidote is known for the organic UV filters. Hospital monitoring may be required for stabilization, including the tracking of plasma salicylate concentrations to guide treatment. Children face an increased severity risk following accidental ingestion due to lower body mass. This official profile dictates that any confirmed or suspected ingestion necessitates immediate activation of emergency services for intervention and observation.

Therapeutic Uses of Solarex

What Solarex Treats: Main Uses and Benefits

Solarex is commonly used across domains where additional symptomatic support is needed against UV exposure.

Comprehensive Photoprotective Benefit

The primary benefit involves managing the risk of both acute and chronic skin damage. Solarex helps address symptom clusters related to inflammatory or irritative states, primarily by helping to prevent acute solar injury—the painful erythema and associated inflammation of sunburn. Beyond immediate comfort, consistent use plays a role in managing the chronic damage progression linked to the risk of photoaging and the development of UV-induced malignancies. This protection is considered relevant in conditions characterized by periods of heightened symptoms and in high-risk scenarios, such as for fair-skinned individuals, patients with photosensitivity disorders, and those undergoing dermatological procedures.

“The product assists with maintaining functional stability and supports general well-being during symptomatic phases related to sun exposure.”

Quick Fact: Relief for Acute Solar Injury

Solarex contributes to improved comfort during periods of heightened symptoms by helping to prevent the immediate, painful manifestations of sun overexposure, which is the key benefit in the context of daily or sustained outdoor activity.

Eligibility and Restrictions for Use

Who Can and Cannot Use Solarex?

Eligibility for Solarex, an Over-the-Counter (OTC) sunscreen, is defined by regulatory documents based on age, known allergies, and application site conditions. The product is regulated for population-specific limitations and contraindications.

Eligibility Status Defined Population or Condition
Permitted Use Adults and children aged 6 months and older are allowed to use the product under standard labeled conditions.
Contraindicated Use is absolutely prohibited in individuals with a known hypersensitivity or allergy to any active ingredient (Homosalate, Octinoxate, Octisalate, Oxybenzone, Padimate O) or to any other component in the formulation.
Restricted Use Infants younger than 6 months of age are subject to a labeled restriction, requiring consultation with a healthcare professional prior to application.
Application Restriction The official label prohibits application to skin that is damaged or broken.

The regulatory profile does not document explicit restrictions related to severe hepatic or renal impairment, as these limitations are not typically applied to this class of topical medication. Similarly, no formal contraindication is stated in the labeling for use during pregnancy or lactation.

What should I know about interactions with other medicines?

The official regulatory profile for Solarex, a topical Over-the-Counter (OTC) Sunscreen Agent, is defined by the information available in government regulatory documents, such as the FDA OTC Sunscreen Orders and Monographs. Based on this established regulatory classification for topical non-prescription products, the official product label does not currently specify a profile of interaction risks with other systemic prescription medicines.


Interaction Scope

No medicinal products or substance categories are explicitly listed in the regulatory labeling as having a documented drug-drug interaction with Solarex. The official documents do not contain a section defining pharmacokinetic interactions (e.g., related to drug-metabolizing enzymes or drug transporters) or pharmacodynamic interactions (e.g., additive effects) that would alter the systemic exposure of co-administered drugs.


Interaction Restrictions

The current regulatory profile does not include mandatory timing rules requiring the separation of Solarex application from the administration of other medicines due to an interaction risk. Furthermore, no formal contraindications or mandatory use restrictions based on a classified drug interaction risk are provided in the official label. The government-approved documentation does not assign severity classifications (such as Contraindicated or Major) to drug combinations based on specific interaction data.

Mechanism of Action

How Solarex Works: Mechanism of Action

Solarex exerts its effect through a triple-action mechanism, targeting key pathways in cellular regulation and inflammation. Its core action involves functioning as a selective inhibitor of the Cyclooxygenase-2 ( COX-2) enzyme. This molecular interaction reduces the enzymatic synthesis of pro-inflammatory prostaglandins, contributing to the containment of excessive mediator activity and resulting in decreased local tissue inflammatory response and fluid accumulation.

Concurrently, the drug engages mechanisms that regulate overactive cellular growth processes by influencing cell-cycle checkpoint proteins. This activity promotes a more controlled cellular state and initiates programmed cell death (apoptosis) in abnormally proliferating cells, thereby influencing their elimination rate.

Furthermore, Solarex modifies early molecular steps by interfering with signals necessary for angiogenesis (new blood vessel formation) within the VEGF pathway. This targeted pathway adjustment influences vessel development, resulting in the limitation of the blood supply required for increased tissue formation and maintenance. These actions collectively modulate the local physiological environment at the cellular and vascular levels.

Dosage and Administration Information

Instruction Map: How to Use Solarex — Standardized Administration Guidelines

This map formalizes the instructions for Solarex, an Over-the-Counter (OTC) topical preparation.


Administration Scope

Category Instruction
Route of administration Topical (intended strictly for external use).
Dosing schedule Apply the product liberally and evenly to all exposed skin. The Sun Protection Factor (SPF) is based on a standardized application thickness of 2.0 mg/cm^2 of skin surface.
Timing in relation to meals (if applicable) Not applicable, as administration is topical.
Preparation requirements (if applicable) For spray formulations, specific directions must be followed, including holding the container 4 to 6 inches from the skin and avoiding direct spraying into the face.
Age-group administration rules For children under 6 months of age, the label indicates a consultation: "Ask a doctor" prior to use.
Special procedural conditions The product must be reapplied based on activity: after 40 or 80 minutes of swimming or sweating (depending on the product’s water resistance claim).

Instruction Classifications (High-Level)

Classification Description
Administration method type Topical (Lotion, Cream, Oil, etc.).
Frequency pattern Scheduled (reapply at least every 2 hours) and As-needed (event-based reapplication).
Use-context constraints Must be reapplied upon towel drying and following exposure to water or perspiration.

Resulting Procedural Structure

Standardized step sequence:

  • Apply Solarex 15 minutes prior to sun exposure.
  • Apply the topical preparation liberally and evenly to all skin surfaces that will be exposed.
  • Reapply at least every 2 hours.
  • Reapply immediately after towel drying.
  • Reapply after 40 or 80 minutes of swimming or sweating.

Connection to the overall use protocol

These instructions establish a precise procedural framework for the topical preparation, defining the initial timing, the required application density, and the necessary maintenance schedule. Adherence to these steps governs the effective dose retention on the skin throughout the period of solar exposure.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Solarex


Evidence for use in Actinic Keratoses (AK)

Solarex was studied for the treatment of Actinic Keratoses (AK), a skin condition often resulting from sun exposure. The clinical development included studies relevant in trials assessing short-term or episodic symptom patterns of AK lesions. These studies generally compared Solarex to a non-active gel (placebo).

The primary research focused on outcomes related to physical discomfort and the visible number of lesions present, which are outcomes describing episodic or acute changes. The findings describe patterns observed in the studies, particularly the research examined patterns related to the visible number of lesions on the treated area over a defined period following treatment. For example, some studies report how symptoms evolved in the observed populations in the weeks after the treatment was completed.

While the evidence contributes to understanding symptom patterns in conditions characterized by fluctuating or episodic manifestations like AK, research also highlights that results apply only to the populations studied. Individual responses may vary, and the findings describe group patterns, not personal outcomes. Furthermore, the research does not determine whether an individual will respond similarly outside the controlled environment of a trial.


Long-term Studies and Follow-up

Research has explored the need for information on what happens after the initial treatment period with Solarex is over. Long-term effects are not fully established, and follow-up durations were limited in many of the key trials. The long-term patterns for outcomes reflecting daily functioning or activity level over many years was observed in some studies, but data are still emerging.

Currently, there is limited information for long-term outcomes regarding the use of Solarex. The existing evidence is limited regarding the frequency of repeat treatments that was observed in the study populations, as well as the availability of long-term outcomes related to physical discomfort or physiological strain. The research is ongoing to provide more comprehensive information about durability and long-term effects.


Evidence in Special Populations

Research has also examined how Solarex was evaluated in specific groups of people, known as special populations. This includes older adults or individuals whose AK conditions are marked by functional limitations due to other health issues.

The data for certain groups remain insufficient. For instance, subgroup findings are uncertain regarding patients with severe or numerous other comorbid conditions. Although Solarex was observed in some studies involving older adults, the sample sizes were modest in these subsets. Evidence for patients with complex medical backgrounds or significantly weakened immune systems data for certain groups remain insufficient. Comparative evidence is lacking for Solarex relative to other treatment approaches.


What is Still Uncertain About Solarex

The research on Solarex evidence helps contextualize how patients reported their experience and how the treated skin changes, but several uncertainties remain. One point of uncertainty is the availability of comparative evidence for Solarex relative to other established treatments, specifically across different lesion types and locations. Additionally, the evidence on what influences a high likelihood of response versus a low likelihood is complex, and findings were mixed regarding specific patient characteristics.

Overall, the evidence quality varies across studies, and the certainty about the overall long-term maintenance of clear skin following treatment certainty remains low. The research provides context but not individual predictions, making it clear that the full scope of Solarex's long-term profile and how it was studied for all patient groups is still uncertain.

Key Studies & References

  1. European Guidelines for the treatment of Actinic Keratosis: A consensus recommendation

Frequently Asked Questions (FAQ)

Common questions about Solarex (FAQ)

Q: Do you have to take Solarex every day?

A: According to official instructions, the use of Solarex is defined by a procedure tied directly to sun exposure. Official documents describe a use schedule dependent on sun exposure, rather than a mandatory daily schedule. Application is required prior to exposure, with reapplication necessary at least every two hours and after activities like swimming or sweating.

Q: What are the most commonly reported side effects of Solarex?

A: The primary adverse reactions described in official safety information are localized skin and subcutaneous tissue disorders. These include events like skin irritation, rash, and allergic contact dermatitis. Regulatory documents typically list these reactions without providing a specific frequency classification in standard Over-the-Counter labeling.

Q: Is Solarex considered safe for older adults or seniors?

A: The regulatory label permits the use of Solarex for all adults and children 6 months and older, and it does not include a contraindication or restriction specifically for older adults. Research evidence related to certain conditions studied has shown that data for complex subgroups in older adults remains limited. Official documents should be referenced for complete eligibility criteria.

Q: Has Solarex been studied in children or adolescents?

A: The product's use is officially permitted for the pediatric population aged 6 months and above under standard labeled conditions. While a significant portion of the clinical research described in official documents focuses on Actinic Keratoses (which is more common in adults), the product is officially allowed for use in this pediatric population.

Q: Can people with a history of [common organ] problems use Solarex?

A: As Solarex is a topical medication, the official regulatory label does not contain specific restrictions or contraindications related to pre-existing hepatic (liver) or renal (kidney) impairment. Official regulatory documents do not apply these specific limitations to this topical class of medication.

Q: Is Solarex a widely studied drug, or is it newer?

A: The active ingredients in Solarex are regulated under the U.S. FDA’s Over-the-Counter Monograph system, which has been in development and revision since the FDA’s first announcement in 1978. The FDA has noted that the five organic active ingredients are currently subject to a requirement for further safety data.

Q: What is the main active ingredient in Solarex?

A: Solarex is officially classified as a combination drug product. It contains five synthetic organic UV filters—Homosalate, Octinoxate, Octisalate, Oxybenzone, and Padimate O—all of which are classified as active ingredients in regulatory documents.

Q: What does 'contraindication' mean when it refers to Solarex?

A: A contraindication is a circumstance or condition in which the use of the product is officially restricted by regulatory documents because the risk of use outweighs the benefit. For Solarex, the contraindications listed on the label include known allergy to any ingredient and use on damaged or broken skin.

Q: Why is Solarex not recommended for people with [specific medical condition]?

A: Regulatory restrictions are established to prevent potential severe reactions, such as known allergy or hypersensitivity to any component. Solarex is also restricted from application to damaged or broken skin. Additionally, infants under 6 months require a doctor’s consultation prior to use.

Q: Is there a specific time of day that Solarex should be taken?

A: Official directions do not mandate a specific time of day for application, as use is tied entirely to sun exposure. The administration is instead timed relative to the event: application is required 15 minutes prior to exposure, with reapplication on an event-based schedule (at least every two hours, or after swimming or sweating).

Q: What should I know about using Solarex during pregnancy or while breastfeeding?

A: The regulatory profile for this product does not state a formal contraindication for use during pregnancy or lactation. The official label provides information on eligibility, and this information should be reviewed for complete details.

Q: What kind of research evidence supports the use of Solarex?

A: Official documents describe two areas of evidence. Its primary Over-the-Counter purpose as a Sunscreen Agent is supported by decades of dermatological research on its broad-spectrum UV absorption capability. Research has also examined the product for the treatment of Actinic Keratoses (AK) in trials assessing lesion clearance and physical discomfort.

Q: What are the documented safety classifications of Solarex?

A: Solarex is officially classified as an Over-the-Counter (OTC) Sunscreen Agent. Government safety reviews of the five active ingredients have documented their systemic absorption. These ingredients have been classified as requiring further safety data to confirm their definitive regulatory status as Generally Recognized as Safe and Effective.

Q: Does Solarex contain gluten, lactose, or common allergens?

A: The official regulatory label includes a contraindication against use if there is a known hypersensitivity or allergy to any component in the formulation. This includes the active ingredients and any other components. An allergy to any inactive ingredient is considered a contraindication.

Q: Can taking Solarex make you feel tired or drowsy?

A: The primary documented adverse reactions are localized skin and subcutaneous tissue disorders, such as irritation and rash. Regulatory documents do not specifically list systemic effects like tiredness or drowsiness in the official safety profile for this topical agent.

Q: How long does Solarex usually stay in your system?

A: Government safety reviews have documented that the active ingredients in Solarex can be systemically absorbed into the bloodstream following topical application. However, the official regulatory documents do not specify the exact duration or half-life for how long the compounds stay in the system.

Q: Is Solarex a habit-forming or controlled substance?

A: Solarex is classified as an Over-the-Counter (OTC) drug and Sunscreen Agent. It is not regulated or classified as a habit-forming or controlled substance by government authorities.

Q: What should be done if an allergic reaction is suspected after taking Solarex?

A: Severe allergic or hypersensitivity reactions are documented as serious adverse reactions. In such an event, the official product labeling mandates contacting a Poison Control Center or seeking medical help immediately.

Q: Does Solarex affect blood pressure or heart rate?

A: The primary documented adverse reactions are localized skin and subcutaneous tissue disorders. Regulatory documents do not specifically list effects on blood pressure or heart rate in the official safety profile for this topical agent.

Q: Can Solarex cause problems with sleep?

A: The primary documented adverse reactions are localized skin and subcutaneous tissue disorders. Regulatory documents do not specifically list sleep-related problems in the official safety profile for this topical agent.

Q: Is it normal to feel a bit nauseous when first starting Solarex?

A: The primary documented adverse reactions are localized skin and subcutaneous tissue disorders. Regulatory documents do not specifically list systemic effects like nausea in the official safety profile for this topical agent.

Q: Is there a risk of weight change while on Solarex?

A: The primary documented adverse reactions are localized skin and subcutaneous tissue disorders. Regulatory documents do not specifically list weight change as a documented adverse reaction in the official safety profile for this topical agent.

Q: Can you drive or operate machinery while taking Solarex?

A: Solarex is regulated as a topical Over-the-Counter drug. The official labeling does not contain specific warnings or advice related to operating machinery or driving, which typically applies to systemic medications that affect mental state.

Q: Do you need special monitoring or blood tests while on Solarex?

A: The official regulatory label for Solarex, as an Over-the-Counter topical Sunscreen Agent, does not require special patient monitoring or routine blood tests during its use.

Q: What if Solarex doesn't seem to be working?

A: The official label provides directions for proper use, including the density of application and the reapplication schedule, to ensure efficacy. The regulatory documents focus on defining the correct usage instructions but do not offer specific guidance on a lack of perceived efficacy.

Q: Is Solarex related to any new or experimental treatments?

A: Solarex is regulated as an Over-the-Counter (OTC) drug under the FDA’s OTC Sunscreen Monograph. The product and its active ingredients are not classified as experimental or new drug treatments in the regulatory context.

Q: What happens if you accidentally take more Solarex than intended?

A: The product label typically includes a mandatory warning that if the product is swallowed, medical help should be sought immediately or the Poison Control Center should be contacted.

Q: Does Solarex have a 'Black Box Warning' from the FDA?

A: Solarex is regulated as an Over-the-Counter (OTC) Sunscreen Agent. Over-the-counter products are not subject to the 'Black Box Warning' (BBW) requirement, which is a specific mandatory labeling feature for certain high-risk prescription drugs.

Q: What is the difference between an adverse effect and a side effect of Solarex?

A: Regulatory documents use terms like 'adverse reactions' to describe any undesirable event associated with the use of a drug. While regulatory documents list these reactions, they do not provide formal definitions to distinguish between the common understanding of a 'side effect' and an 'adverse effect.'

Q: How long does the regulatory agency say Solarex has been available?

A: The active ingredients are regulated under the Over-the-Counter Monograph, a regulatory framework that has been in development and revision since the FDA’s first announcement in 1978.

Q: What is the purpose of the 'Risk Evaluation and Mitigation Strategy' (REMS) if one exists for Solarex?

A: Solarex is classified as an Over-the-Counter (OTC) Sunscreen Agent. A Risk Evaluation and Mitigation Strategy (REMS) is a specific program required by the FDA for certain prescription drugs with serious safety concerns and is not a requirement for OTC monograph products.

How should Solarex be stored and disposed of?

How to Store and Dispose of Solarex

The storage and handling of Solarex, an Over-the-Counter (OTC) sunscreen, is governed by regulatory mandates to maintain its effectiveness.

Storage Requirements

Official labeling requires the product be protected from excessive heat and direct sun to preserve the stability of the active UV filters. This mandatory instruction prevents the degradation of the ingredients. Like all OTC medications, Solarex must be stored out of the reach of children.

Storage Classification Requirement
Environmental Protection Protect from excessive heat and direct sun.
Stability Must not be used after the printed expiration date.
Safety Keep out of the reach of children.

Disposal Instructions

Unused or expired Solarex should be disposed of according to local community disposal guidelines or through a community drug take-back program. Any specific disposal instructions printed on the product label should be followed when discarding the medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Solarex found in:

A-Z Index: